Latest KFF Health News Stories
Video: High Drama No Stranger At Congressional Health Care Hearings
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
El alto costo del sexo: aseguradoras no pagan por drogas para resolver problemas
Medicare y aseguradoras privadas suelen no pagar los costos de medicamentos que ayudan a superar disfunciones sexuales comunes en adultos mayores.
The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that’s not medically necessary to pay for.
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
Estadounidenses van a México a comprar insulina por un costo mucho más bajo
Millones cruzan la frontera para tratamientos y para comprar medicinas. La pregunta es si es una práctica legal. En Utah establecen turismo médico.
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
